The Conflict Between Human Rights And Biotechnological Evolution
By Srinivas Raman,
Eurasia Review
| 04. 11. 2015
Untitled Document
In 1997, Dolly the sheep became the first mammal ever to be successfully cloned. This was a major breakthrough in the field of genetic engineering and since then scientists worldwide have been trying to replicate the success in other mammals such as pigs, mice, cows, primates and even humans. However, the idea of genetic modification by using biotechnology existed way before Dolly did and was a cornerstone to the Nazi ideology and eugenics was used as a justification to commit heinous crimes against humanity such as genocide.[1]
Today, one of the most perilous issues but unfortunately one which has gained scarce global attention is whether humans should be genetically modified. This question raises several moral, ethical, legal and scientific considerations and is an extremely sensitive issue. The startling contemporary truth is that technology is at a stage where it is possible for scientists to clone humans and genetically engineer them.[2]
Genetically modifying humans has the potential to violate human rights and freedom and could possibly lead to catastrophic consequences for the human race if legalized and encouraged. Manipulating...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By Ryan Knutson and Jessica Mendoza, The Journal. | 03.27.2026
Genetically engineered babies are banned in the U.S. But that isn’t stopping Silicon Valley tech titans from trying to make one. In this final installment from The Journal’s investigation into the fringes of the fertility industry, WSJ’s Emily Glazer reports...
By Antonio Regalado, MIT Technology Review | 03.30.2026
After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey “organ sacks” as an alternative to animal testing.
In...
